1,068 reports of this reaction
2.2% of all GALCANEZUMAB GNLM reports
#9 most reported adverse reaction
ACCIDENTAL UNDERDOSE is the #9 most commonly reported adverse reaction for GALCANEZUMAB GNLM, manufactured by Eli Lilly and Company. There are 1,068 FDA adverse event reports linking GALCANEZUMAB GNLM to ACCIDENTAL UNDERDOSE. This represents approximately 2.2% of all 49,086 adverse event reports for this drug.
Patients taking GALCANEZUMAB GNLM who experience accidental underdose should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ACCIDENTAL UNDERDOSE is a less commonly reported adverse event for GALCANEZUMAB GNLM, but still significant enough to appear in the safety profile.
In addition to accidental underdose, the following adverse reactions have been reported for GALCANEZUMAB GNLM:
The following drugs have also been linked to accidental underdose in FDA adverse event reports:
ACCIDENTAL UNDERDOSE has been reported as an adverse event in 1,068 FDA reports for GALCANEZUMAB GNLM. This does not prove causation, but indicates an association observed in post-market surveillance data.
ACCIDENTAL UNDERDOSE accounts for approximately 2.2% of all adverse event reports for GALCANEZUMAB GNLM, making it a notable side effect.
If you experience accidental underdose while taking GALCANEZUMAB GNLM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.